211 related articles for article (PubMed ID: 9600967)
1. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Volpert OV; Lawler J; Bouck NP
Proc Natl Acad Sci U S A; 1998 May; 95(11):6343-8. PubMed ID: 9600967
[TBL] [Abstract][Full Text] [Related]
2. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts.
Rofstad EK; Graff BA
J Invest Dermatol; 2001 Nov; 117(5):1042-9. PubMed ID: 11710911
[TBL] [Abstract][Full Text] [Related]
4. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
[TBL] [Abstract][Full Text] [Related]
5. Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.
Hanyu A; Kojima K; Hatake K; Nomura K; Murayama H; Ishikawa Y; Miyata S; Ushijima M; Matsuura M; Ogata E; Miyazawa K; Imamura T
Cancer Sci; 2009 Nov; 100(11):2085-92. PubMed ID: 19719773
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model.
Mah-Becherel MC; Céraline J; Deplanque G; Chenard MP; Bergerat JP; Cazenave JP; Klein-Soyer C
Br J Cancer; 2002 Mar; 86(5):803-10. PubMed ID: 11875746
[TBL] [Abstract][Full Text] [Related]
7. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
8. PPARalpha deficiency in inflammatory cells suppresses tumor growth.
Kaipainen A; Kieran MW; Huang S; Butterfield C; Bielenberg D; Mostoslavsky G; Mulligan R; Folkman J; Panigrahy D
PLoS One; 2007 Feb; 2(2):e260. PubMed ID: 17327920
[TBL] [Abstract][Full Text] [Related]
9. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor (NGF) has an anti-tumor effects through perivascular innervation of neovessels in HT1080 fibrosarcoma and HepG2 hepatitis tumor in nude mice.
Kawasaki H; Goda M; Fukuhara S; Hashikawa-Hobara N; Zamami Y; Takatori S
J Pharmacol Sci; 2019 May; 140(1):1-7. PubMed ID: 31178329
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.
Mori A; Arii S; Furutani M; Hanaki K; Takeda Y; Moriga T; Kondo Y; Gorrin Rivas MJ; Imamura M
Int J Cancer; 1999 Mar; 80(5):738-43. PubMed ID: 10048976
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).
Iwamoto Y; Nomizu M; Yamada Y; Ito Y; Tanaka K; Sugioka Y
Br J Cancer; 1996 Mar; 73(5):589-95. PubMed ID: 8605091
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.
Zaslavsky A; Baek KH; Lynch RC; Short S; Grillo J; Folkman J; Italiano JE; Ryeom S
Blood; 2010 Jun; 115(22):4605-13. PubMed ID: 20086246
[TBL] [Abstract][Full Text] [Related]
14. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
15. An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.
Runkel S; Hunter N; Milas L
Radiat Res; 1991 May; 126(2):237-43. PubMed ID: 1708892
[TBL] [Abstract][Full Text] [Related]
16. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice.
Bremer C; Mustafa M; Bogdanov A; Ntziachristos V; Petrovsky A; Weissleder R
Radiology; 2003 Jan; 226(1):214-20. PubMed ID: 12511693
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.
Zhang Y; Deng Y; Luther T; Müller M; Ziegler R; Waldherr R; Stern DM; Nawroth PP
J Clin Invest; 1994 Sep; 94(3):1320-7. PubMed ID: 7521887
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
Shimo T; Nakanishi T; Nishida T; Asano M; Sasaki A; Kanyama M; Kuboki T; Matsumura T; Takigawa M
Oncology; 2001; 61(4):315-22. PubMed ID: 11721179
[TBL] [Abstract][Full Text] [Related]
19. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
20. Endogenous regulators of angiogenesis--emphasis on proteins with thrombospondin--type I motifs.
Carpizo D; Iruela-Arispe ML
Cancer Metastasis Rev; 2000; 19(1-2):159-65. PubMed ID: 11191055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
